Laryngeal squamous cell carcinoma (LSCC) from different subsites have distinct presentations and prognosis. In this study, we carried out a multiomic comparison of LSCC subsites. The
Cancer Genome Atlas (TCGA) LSCC cohort was analyzed in the R statistical environment for differences between supraglottic and glottic
cancers in single
nucleotide variations (SNVs), copy number alterations (CNAs),
mRNA abundance,
protein abundance, pathway overrepresentation, tumor microenvironment (TME),
hypoxia status, and patient outcome. Supraglottic
cancers had significantly higher overall and smoking-associated SNV mutational load. Pathway analysis revealed upregulation of muscle related pathways in glottic
cancer and neural pathways in supraglottic
cancer.
Proteins involved in
cancer relevant signaling pathways including PI3K/Akt/mTOR, the cell cycle, and PDL1 were differentially abundant between subsites. Glottic and supraglottic
tumors have different molecular profiles, which may partially account for differences in presentation and response to
therapy.